| 呼吸道合胞病毒载体疫苗研究进展 |
| |
| 引用本文： | 付远辉,何金生,洪涛.呼吸道合胞病毒载体疫苗研究进展[J].中国生物工程杂志,2012,32(1):92-96. |
| |
| 作者姓名： | 付远辉 何金生 洪涛 |
| |
| 作者单位： | 1. 北京交通大学生命科学与生物工程研究院 北京 100044;
2. 中国疾病预防控制中心病毒病预防控制所院士实验室 北京 100052 |
| |
| 基金项目： | 国家自然科学基金，北京市自然科学基金，中国博士后科学基金 |
| |
| 摘 要： | 人呼吸道合胞病毒(human respiratory syncytial virus, RSV)是引起婴幼儿下呼吸道感染的最重要的病毒病原,RSV载体疫苗可在人细胞内从头合成,形成的蛋白质构象与RSV自然感染后表达的完全相同,不会导致抗原表位的丧失或变化,形成的免疫力更利于抵抗随后的自然感染;经黏膜途径免疫不会产生疾病增强作用,且能突破母传抗体的干扰,因而受到广泛关注。对近年来RSV载体疫苗的研究进展进行了综述。
|
| 关 键 词： | 呼吸道合胞病毒 载体疫苗 |
| 收稿时间： | 2011-10-08 |
| 修稿时间： | 2011-11-03 |
Advances in Live Vector-based Vaccines Against Respiratory Syncytial Virus |
| |
| FU Yuan-hui,HE Jin-sheng,HONG Tao.Advances in Live Vector-based Vaccines Against Respiratory Syncytial Virus[J].China Biotechnology,2012,32(1):92-96. |
| |
| Authors: | FU Yuan-hui HE Jin-sheng HONG Tao |
| |
| Institution: | 1,2(1 College of Life Sciences & Bioengineering,Beijing Jiaotong University,Beijing 100044,China)(2 Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 100052,China) |
| |
| Abstract: | Human respiratory syncytial virus(RSV) is the leading viral agent of serious respiratory disease in infants and young children worldwide,infecting nearly all children one or more times by age 2.An intranasal live vector-based RSV vaccine mimics natural infection and presumably synthetized proteins in conformation similar these synthetized by natural infection.An intranasal live vector-based RSV vaccine is able to escape the immunosuppressive effects of maternal serum antibodies and avoid the immune-mediated enhanced disease.The advances in the live vector-based RSV vaccine is reviewed. |
| |
| Keywords: | Respiratory syncytial virus Vector-based vaccine |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《中国生物工程杂志》浏览原始摘要信息 |
| 点击此处可从《中国生物工程杂志》下载免费的PDF全文 |
